ORENCIA

Google image searchProduct monograph

Active ingredient

abatacept, 250 MG/VIAL

DIN: 02282097

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Schedule: Prescription

Company: BRISTOL-MYERS SQUIBB CANADA

Date: 08-AUG-2006

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AA — Selective immunosuppressants (ATC, ATC/DDD)
• L04AA24 — ABATACEPT (ATC/DDD)

Reference brand drug: Orencia

External Links for Orencia

Search on Google

• Orencia side effects
• Orencia dosage
• abatacept side effects
• abatacept dosage

Bristol-Myers Squibb Canada

Go to Bristol-Myers Squibb website to see drug product details. Sometimes you can find orencia photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.